Efficacy and Safety Phase II Dose-ranging Study of SR-T100 to Treat Actinic Keratosis
This study is currently recruiting participants.
Verified March 2013 by G&E Herbal Biotechnology Co., LTD
Sponsor:
G&E Herbal Biotechnology Co., LTD
Information provided by (Responsible Party):
G&E Herbal Biotechnology Co., LTD
ClinicalTrials.gov Identifier:
NCT01516515
First received: January 17, 2012
Last updated: March 11, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |